Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Norsk Hydro ASA engages in producing and supplying alumina and primary aluminum. It operates through the following segments: Hydro Bauxite & Alumina, Hydro Aluminium Metal, Hydro Extrusions, Hydro Energy, Hydro Metal Markets, and Other. The Hydro Bauxite & Alumina segment includes bauxite mining activities, production of alumina and related commercial activities, primarily the sale of alumina. The Hydro Aluminium Metal segment includes primary aluminium production and casting activities. The Hydro Extrusions segment delivers products within extrusion profiles, building systems and precision tubing, and is operating several recycling facilities, both integrated with its extrusion plants and separate plants. The Hydro Energy includes operating and commercial responsibility for Hydro's power stations in Norway, a trading and wholesale business in Brazil, and energy sourcing for Hydro’s world-wide operations. The Hydro Metal Markets includes all sales activities relating to products from primary metal plants and operational responsibility for stand-alone recyclers as well as physical and financial metal trading activities. The company was founded on December 2, 1905 and is headquartered in Oslo, Norway.

Cancer Research Ventures Ltd. engages in the business of research and experimental development on biotechnology. It provides medical products. The company is headquartered in London, the United Kingdom.

Nalo Therapeutics is a biotech company that develops pharmaceutical products intended to treat hematological and solid tumors. Its products are small molecule-based medicines for the treatment of cancer, enabling customers to purchase medicines to treat cancer cells that originate from uncontrolled cellular growth. The company was founded in 2017 and is based in New Castle, Delaware.

Shanghai Bode Gene Development Co., Ltd., established on 1998-03-22, Business scope includes bioengineering,Technology transfer in the field of genetic engineering expertise,technology development,technical consulting,Technical services and manufacture of related reagents and equipment,Sales;Bioengineering and Genetic Engineering Products,electronics,Chemical Products(In addition to dangerous goods)import and export business. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Attobio Pharmaceutical (Suzhou) Co. Ltd. engages in the development of biomedical technology and products. Its business activities include the innovation of products designed to improve the level of preventive medicine and early detection of disease to provide accurate diagnostic techniques, and the import and export of biological reagents and biotechnology. The company was founded by Xiao Jia Chang on May 7, 2012 and is headquartered in Suzhou, China.

Norks Hydro ASA is a private company headquartered in Norway that produces and sells aluminium.

Part of GemVax & KAEL Co., Ltd., Gemvax AS is a company headquartered in Porsgrunn, Norway, that develops and manufactures pharmaceuticals. It was founded by Mona Elisabeth M��ller. Gemvax AS was acquired by VaxOnco, Inc. from Pharmexa An on October 30, 2008.\nThe company says this about itself: Based in Seoul, Korea, GemVax Group operates in two main areas: environmental protection and biopharmaceutical drug development. The biopharmaceutical arm, GemVax & KAEL was formed in 1998 and comprises Samsung Pharm, GemVax and FEELingK. It has brought to the market the first-in-class immunotherapeutic drug RIAVAX��inj for pancreatic cancer. Based on telomerase modification, the company's lead candidate GV1001 also has potential other indications in cancer and neurodegenerative diseases.

Beijing Fendai Medical Technology Co., Ltd., established on 2005-05-20, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Computer System Services;Basic software service,Application software service;software development;Economic and Trade Consulting;business management;Business Management Consulting;Health Advisory(Except for medical treatment activities subject to approval),health management(Except for medical treatment activities subject to approval);Undertake exhibition and display activities;Medical Research and Experimental Development;Sales of daily necessities,cosmetic,stationery,Clothing and shoes,crafts,communication equipment,Wujinjiaodian(E-bike not included),Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals),medical instrumentsIkind.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

American Cyanamid Company was a U.S.-based diversified company with businesses in several fields. The company was a manufacturer of agricultural chemicals, cosmetics, perfumes, building products, plastics and pharmaceuticals. The company was listed as a top 100 manufacturing company by Fortune magazine in the 1970s. Cyanamid was founded in 1907 and employed over 100,000 people around the world by 2000. The company maintained a monopoly over tetracycline, an antibiotic used against bacterial infections. A theft of the organism led to the loss of the monopoly as rival companies were able to produce generic versions of the formula, leading to huge losses to the company. The company sold most of its businesses in the early 2000s and is now operated under the name Cytec.  

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Diamond Innovations, Inc. manufactures and supplies diamond, cubic boron nitride and polycrystalline products. The company is headquartered in Worthington, OH.

Suzhou Southeast Pharmaceuticals Co., Ltd. engages in research and development, manufacture, and sales of medical drugs. It also provides improvement and quality control of marketed drugs. The company was founded on May 28, 2008 and is headquartered in Suzhou, China.

Oncos Therapeutics develops new cancer therapies based on its next generation oncolytic viruses. The company's unique Advanced Therapy Access Program was started in 2007 for cancer patients in whom standard-of-care therapies have failed. Today, 200 patients have undergone individually tailored oncolytic virus therapy suggesting strong safety and efficacy. The program is based on extensive scientific research at the University of Helsinki and serves as the foundation for ongoing clinical development.